This book investigates the complex relationship between calcium channel blockers and the development of atherosclerosis. It synthesizes current research to explore how these widely used medications might influence the progression of arterial disease. The work aims to provide a comprehensive overview for researchers and clinicians.

The Authority Perspective: This text is recognized as a significant contribution to understanding the nuanced effects of calcium antagonism on atherosclerosis. It is valued for its detailed exploration of the underlying science and its critical review of clinical evidence. The book serves as a key reference for those seeking to grasp the intricate interplay between cardiovascular pharmacology and disease progression.